These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9441542)

  • 1. [The significance of gestagens in treatment of mastopathy].
    Schweppe KW
    Zentralbl Gynakol; 1997; 119 Suppl 2():54-8. PubMed ID: 9441542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of histologic mastopathy diagnosis using quantitative procedures].
    Guski H; Simon H; Freitag A; Wenzelides K; Hufnagl P; Winzer KJ; Wolff H; Buchholz J
    Zentralbl Chir; 1986; 111(15):907-14. PubMed ID: 3765935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestins in the menopause in healthy women and breast cancer patients.
    Pasqualini JR
    Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The peripheral hormone level in premenopausal patients with benign breast changes and their modification by various hormone therapies].
    Bohnet HG; Bertram M
    Gynakologe; 1989 Aug; 22(4):255-61. PubMed ID: 2676761
    [No Abstract]   [Full Text] [Related]  

  • 9. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzyme therapy in treatment of mastopathy. A randomized double-blind clinical study].
    Rammer E; Friedrich F
    Wien Klin Wochenschr; 1996; 108(6):180-3. PubMed ID: 8650928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of action of danazol, personal clinical experiences and guidelines for the treatment of benign breast diseases].
    Schindler AE; Schindler EM
    Gynakologe; 1989 Aug; 22(4):271-3. PubMed ID: 2676763
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sex steroids on proliferation in normal mammary tissue.
    Söderqvist G
    Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pill and the breast.
    Drife JO
    IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Danazol therapy in benign breast diseases].
    Goebel R; Junkermann H; von Fournier D
    Gynakologe; 1989 Aug; 22(4):262-70. PubMed ID: 2676762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endocrinology of mastopathy and small breast cancer].
    Huber J; Vytiska E
    Wien Med Wochenschr; 1987 Mar; 137(5-6):116-9. PubMed ID: 3037805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.